HAB Pharmaceuticals
Cough & Cold1X15ml
Prescription required
This medicine is dispensed only against a valid prescription from a registered medical practitioner. You’ll be asked to upload it at checkout, and a pharmacist reviews it before dispatch.
Prescription policyYou save ₹26.00 · Inclusive of all taxes
OTRISIGN NASAL DROP by HAB Pharmaceuticals — Drops containing Xylometazoline Hydrochloride 0.10% and Benzalkonium Chloride 0.01% (made in India).
Available on order. The seller arranges supply before dispatch.
OTRISIGN NASAL DROP is a drops formulation marketed by HAB Pharmaceuticals. Its declared composition consists of XYLOMETAZOLINE HYDROCHLORIDE 0.10% and BENZALKONIUM CHLORIDE 0.01%. This product entry describes the formulation, form and origin. For clinical use, precise instructions and medical guidance, refer to the product label and consult a healthcare professional or pharmacist. The information here is limited to the vendor-supplied facts and does not replace professional medical advice.
OTRISIGN NASAL DROP is a medicine product from HAB Pharmaceuticals presented as nasal drops. The supplied composition is XYLOMETAZOLINE HYDROCHLORIDE 0.10% combined with BENZALKONIUM CHLORIDE 0.01%. The product is provided in drops form and originates from India. This listing provides factual product information only. For any clinical indications, dosing, contraindications, side effects or other therapeutic details, please consult the product label, your prescribing doctor or a pharmacist. Do not use medical advice from this description in place of professional guidance; always follow the instructions printed on the packaging and the leaflet supplied with the product.
The vendor-supplied facts do not list specific medical uses or approved indications for OTRISIGN NASAL DROP. For information on what conditions this product is intended to treat, please consult the product label and package leaflet, or speak with your prescribing physician or a pharmacist. They can confirm the approved indications and advise whether this product is appropriate for your clinical needs. This listing provides composition and formulation details only.
Specific therapeutic benefits, indications or claimed effects are not included in the vendor-supplied facts. For information about intended clinical benefits or approved uses of OTRISIGN NASAL DROP, please consult the product label, the patient information leaflet that comes with the packaging, or speak with your prescribing physician or pharmacist. They can explain what the product is used for and whether it is suitable for your condition.
XYLOMETAZOLINE HYDROCHLORIDE 0.10% + BENZALKONIUM CHLORIDE 0.01%
The appropriate method of use and dosing information are not provided in the vendor facts. Refer to the product label, package leaflet, or follow directions given by your prescribing doctor or pharmacist for how to use OTRISIGN NASAL DROP. If you have questions about the application technique, timing, or frequency, ask a pharmacist or the healthcare professional who recommended the product. Do not rely on this listing for step-by-step administration instructions.
Before using OTRISIGN NASAL DROP, read the product label and leaflet supplied with the packaging. Check expiry date, intactness of the seal and packaging. Keep the product out of reach of children. Do not use if the packaging is damaged or if you are unsure about the product. For pregnancy, breastfeeding, pre-existing medical conditions, or concurrent medicines, consult your doctor or pharmacist before use. For any uncertainty about safety, ask a healthcare professional to review suitability for your situation. Detailed side effect information and safety profile are not provided in the supplied product facts. For known adverse effects, precautions, and what to do if you experience any symptoms, check the product leaflet enclosed with the packaging or consult your prescribing doctor or pharmacist. If you notice any unexpected reactions after using the product, stop use and seek medical advice promptly as directed by a healthcare professional.
Specific warnings, contraindications and age restrictions are not provided in the supplied facts. General precautions include: read the package leaflet before use, keep out of reach of children, check expiry date and packaging integrity. For warnings that apply to your health status — including pregnancy, breastfeeding, chronic illness, ocular conditions, or medication use — consult the product label and your healthcare professional. Do not use the product without confirming suitability with a qualified professional. No drug interaction information is included in the vendor-supplied facts. For potential interactions with other medicines, supplements or medical conditions, consult the product leaflet, your prescribing doctor, or a pharmacist. They can review your current medications and advise whether any interaction risks exist. Do not assume that this product is safe to use with other treatments without professional confirmation.
Specific storage instructions are not supplied in the vendor facts. Store the product as directed on the packaging and in the patient leaflet. If storage instructions are unclear, keep the product in its original container, avoid exposure to extreme temperatures and direct sunlight, and consult a pharmacist or the prescribing healthcare professional for advice. Dispose of the product according to label instructions and local regulations if expired or if packaging is damaged.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
OTRISIGN NASAL DROP is listed as a medicine. Use it only as directed by a registered medical practitioner.
Yes. It is dispensed only against a valid prescription from a registered medical practitioner, which you upload at checkout.
Specific storage instructions are not supplied in the vendor facts. Store the product as directed on the packaging and in the patient leaflet. If storage instructions are unclear, keep the product in its original container, avoid exposure to extreme temperatures and direct sunlight, and consult a pharmacist or the prescribing healthcare professional for advice. Dispose of the product according to label instructions and local regulations if expired or if packaging is damaged.